Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions

Details for Australian Patent Application No. 2008213836 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Jia, Qi; Fu, Jianmin; Sun, Jianyu; Liu, Shifeng; Chowdhury, Sultan; Kamboj, Rajender; Wood, Mark

Agent Davies Collison Cave

Pub. Number AU-A-2008213836

PCT Pub. Number WO2008/097991

Priority 60/888,253 05.02.07 US; 60/912,122 16.04.07 US

Filing date 5 February 2008

Wipo publication date 14 August 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/097991 Priority application(s): WO2008/097991

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008213849-Methods and systems for delivering sponsored out-of-band passwords

2008213833-Pumping in a higherorder mode that is substantially identical to a signal mode